An organic sodium salt having 8-bromoguanosine 3',5'-cyclic phosphate as the counterion. A membrane permeable cGMP analogue that activates protein kinase G (PKG). It is 4.3-fold more potent than cGMP in activating PKG1α and promotes relaxation of tracheal and vascular smooth muscle tissue in vitro.
Stars
This entity has been manually annotated by the ChEBI Team.
A drug used to produce muscle relaxation (excepting neuromuscular blocking agents). Its primary clinical and therapeutic use is the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. Also used for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis.
sodium 8-bromo-3',5'-cyclic GMP
(CHEBI:64104)
has part
8-bromo-3',5'-cyclic GMP(1−)
(CHEBI:64107)
sodium 8-bromo-3',5'-cyclic GMP
(CHEBI:64104)
has role
muscle relaxant
(CHEBI:51371)
sodium 8-bromo-3',5'-cyclic GMP
(CHEBI:64104)
has role
protein kinase G agonist
(CHEBI:64105)
sodium 8-bromo-3',5'-cyclic GMP
(CHEBI:64104)
is a
organic sodium salt
(CHEBI:38700)
IUPAC Name
sodium 8-bromoguanosine 3',5'-phosphate
Synonyms
Sources
8-bromo cGMP sodium salt
ChEBI
8-bromoguanosine 3',5'-cyclic phosphate sodium
ChEBI
8-bromoguanosine 3',5'-cyclic phosphate sodium salt